Beyond GDF-15, we have previously shown that osteoprotegerin (OPG), OPN, fibroblast growth factor 23 (FGF-23), and TFF3 are important biomarkers for prediction of bleeding in patients with CAD or AF [21, 34, 35]. The gene discussed is TFF3; the disease is coronary artery disorder.